These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 3050853

  • 1. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
    Käyhty H, Peltola H, Eskola J.
    Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
    [Abstract] [Full Text] [Related]

  • 2. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA.
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO, Wenzel JG, Ashe KM, Samuelson JS.
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [Abstract] [Full Text] [Related]

  • 4. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J, Käyhty H, Takala AK, Peltola H, Rönnberg PR, Kela E, Pekkanen E, McVerry PH, Mäkelä PH.
    N Engl J Med; 1990 Nov 15; 323(20):1381-7. PubMed ID: 2233904
    [Abstract] [Full Text] [Related]

  • 5. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD, Ward JI, Chiu CE, Marcy SM, Gordon L, Hendley JO, Meier K, Marchant CD, McVerry P.
    Pediatrics; 1990 Mar 15; 85(3):288-93. PubMed ID: 2304781
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV, Johnson CL, Phipps DC, Myers MG, Eby R, Smith DH.
    Pediatrics; 1990 Oct 15; 86(4):527-34. PubMed ID: 2216616
    [Abstract] [Full Text] [Related]

  • 7. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Peltola H, Käyhty H, Sivonen A, Mäkelä H.
    Pediatrics; 1977 Nov 15; 60(5):730-7. PubMed ID: 335348
    [Abstract] [Full Text] [Related]

  • 8. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK, Daum RS.
    Pediatrics; 1990 Apr 15; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH, Eskola J, Peltola H, Takala AK, Käyhty H.
    Pediatrics; 1990 Apr 15; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB, Moggio MV, Drucker RP, Wilfert CM.
    Pediatr Infect Dis J; 1990 Sep 15; 9(9):632-5. PubMed ID: 2235187
    [Abstract] [Full Text] [Related]

  • 11. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Wong VK, Quagliata R, Adler R, Kim KS.
    Am J Dis Child; 1991 Jul 15; 145(7):742-5. PubMed ID: 2058604
    [Abstract] [Full Text] [Related]

  • 12. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Shapiro ED, Berg AT.
    Pediatrics; 1990 Apr 15; 85(4 Pt 2):643-7. PubMed ID: 2179854
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
    Eskola J, Peltola H, Takala AK, Käyhty H, Hakulinen M, Karanko V, Kela E, Rekola P, Rönnberg PR, Samuelson JS.
    N Engl J Med; 1987 Sep 17; 317(12):717-22. PubMed ID: 3306379
    [Abstract] [Full Text] [Related]

  • 14. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM.
    Pediatrics; 1990 Apr 17; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [Abstract] [Full Text] [Related]

  • 15. Haemophilus influenzae type b immunization of children with sickle cell diseases.
    Frank AL, Labotka RJ, Rao S, Frisone LR, McVerry PH, Samuelson JS, Maurer H, Yogev R.
    Pediatrics; 1988 Oct 17; 82(4):571-5. PubMed ID: 3262857
    [Abstract] [Full Text] [Related]

  • 16. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine.
    Rubin LG, Voulalas D, Carmody L.
    Pediatrics; 1989 Sep 17; 84(3):509-13. PubMed ID: 2788866
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.
    Käyhty H, Peltola H, Eskola J, Rönnberg PR, Kela E, Karanko V, Mäkelä PH.
    Pediatrics; 1989 Dec 17; 84(6):995-9. PubMed ID: 2587155
    [Abstract] [Full Text] [Related]

  • 18. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].
    Reinert P, Postel-Vinay A, Bessa E, Hessel L, Schulz D, Cadoz M.
    Ann Pediatr (Paris); 1989 Jan 17; 36(1):20-5. PubMed ID: 2784652
    [Abstract] [Full Text] [Related]

  • 19. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen.
    Bewley KM, Schwab JG, Ballanco GA, Daum RS.
    Pediatrics; 1996 Nov 17; 98(5):898-904. PubMed ID: 8909483
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.
    Lenoir AA, Granoff PD, Granoff DM.
    Pediatrics; 1987 Aug 17; 80(2):283-7. PubMed ID: 3112729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.